243 related articles for article (PubMed ID: 29061503)
1. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
MacMillan TE; Cavalcanti RB
Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
MacMillan TE; Tang T; Cavalcanti RB
Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
[TBL] [Abstract][Full Text] [Related]
4. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
[TBL] [Abstract][Full Text] [Related]
5. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
[TBL] [Abstract][Full Text] [Related]
7. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
8. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
Ochiai H; Uenishi E
Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial.
Pakchotanon K; Kanjanasuphak N; Chuasuwan A; Gojaseni P; Chittinandana A
Sci Rep; 2024 Mar; 14(1):7487. PubMed ID: 38553491
[TBL] [Abstract][Full Text] [Related]
10. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
Ward FL; Tobe SW; Naimark DMJ
Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
[TBL] [Abstract][Full Text] [Related]
11. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
[TBL] [Abstract][Full Text] [Related]
12. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hyponatremia.
Sterns RH; Hix JK; Silver S
Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
[TBL] [Abstract][Full Text] [Related]
14. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.
Gunther M; Witenko CJ; Prust M; Salerno D; Berger K
J Intensive Care Med; 2022 Jun; 37(6):825-832. PubMed ID: 34286612
[TBL] [Abstract][Full Text] [Related]
15. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
Watterworth BS; Noorani RJ
A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
[TBL] [Abstract][Full Text] [Related]
17. Oral ddAVP for nighttime urinary incontinence in characterized nursing home residents: a pilot study.
Johnson TM; Miller M; Tang T; Pillion DJ; Ouslander JG
J Am Med Dir Assoc; 2006 Jan; 7(1):6-11. PubMed ID: 16413428
[TBL] [Abstract][Full Text] [Related]
18. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
Choi EY; Park JS; Kim YT; Park SY; Kim GH
Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
George JC; Zafar W; Bucaloiu ID; Chang AR
Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
[TBL] [Abstract][Full Text] [Related]
20. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
Sharma R; Stein D
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
